Om

Alzai Health Corp. Common Stock represents ownership in Alzai Health Corp., a healthcare technology company focused on artificial intelligence-driven disease risk screening. The company develops non-invasive tools that analyze routine medical and biomarker data to identify elevated risk for conditions such as Alzheimer’s disease, mild cognitive impairment, and related dementias. Its platform is designed to support earlier detection, risk stratification, and timely clinical intervention by fitting into existing healthcare workflows and electronic medical record systems. Alzai Health serves a range of healthcare stakeholders, including providers, insurers, pharmaceutical companies, and research organizations, with particular relevance to clinical trials and population health screening. Headquartered in Toronto, Canada, and founded in 2024, the company operates at the intersection of healthcare technology and diagnostics, aiming to make disease risk assessment more accessible and data-driven.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALZAI HEALTH MED ENDAVU: Køb Alzai Health ($ALZI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alzai Health, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.